The OnvatiLimab Biosimilar Anti-B7-H5 Antibody is a cutting-edge product designed for research involving B7-H5, a cell surface molecule involved in immune regulation and immune checkpoint pathways. This biosimilar antibody, derived from innovative biotechnology, is highly specific and reactive with human samples, making it ideal for in vitro studies and preclinical research.The B7-H5 protein, also known as V-domain Ig suppressor of T cell activation (VISTA), plays a crucial role in regulating T cell function and maintaining immune tolerance. It has been identified as a potential target for cancer immunotherapy and autoimmune disease treatment. The OnvatiLimab Biosimilar Anti-B7-H5 Antibody allows for the detection and analysis of B7-H5 protein expression in various cell types, providing valuable insights for immunology and oncology research.
Researchers and pharmaceutical companies can utilize this advanced antibody to further explore the mechanisms of immune evasion and immune suppression in cancer and autoimmune disorders. By understanding the role of B7-H5 in immune response modulation, innovative therapeutic strategies can be developed to enhance immune surveillance or restore immune balance in disease settings. Unlock the potential of B7-H5 research with the OnvatiLimab Biosimilar Anti-B7-H5 Antibody.
Product Name:
Onvatilimab (Anti-B7-H5) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0095
Target:
B7-H5
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
JNJ-61610588
Description:
Anti-B7-H5(onvatilimab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
